Alemtuzumab (Anti-CD52)

Alemtuzumab (Anti-CD52) is a humanized monoclonal antibody targeting against CD52. Alemtuzumab selectively targets the CD52 antigen to induce profound lymphocyte depletion, followed by recovery of T and B cells with regulatory phenotypes. MW:145.5 KD.

• Supplier: Selleck Chemicals
• Product #: A2553
• Sku #: A2553-1mg*25